Abstract
This study was conducted to elucidate the prognostic value of patient-assessed quality-of-life (QL) scores in cancer patients. QL was assessed in 47 consecutive patients with advanced or end-stage breast cancer using the Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs (QOL-ACD). The data collected from 19 of the 47 patients, who completed QL questionnaires more than twice before dying of cancer, were analyzed. The relationships between the QL scores and subsequent survival were examined at two assessment points, being the first and last assessment points of each of the 19 patients; corresponding respectively to median survival times of 14 and 4 months. The prognostic significance of the changes in QL scores that occurred over 3 months before the last assessment point was also examined. At the last assessment point, the scores of the physical aspects of QL were significantly related to survival. The change in scores of both overall QL and the physical aspects of QL were also significant predictors of survival. On the other hand, neither the scores nor the change in scores of the psychological and social aspects of QL was significant. This study indicates that both QL scores and changes in QL scores are promising prognostic predictors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Shimozuma K, Sonoo H, Ichihara K, Kurebayashi J, Miyake K, Yoshikawa K, Ota K (1994) Analysis of factors associated with quality of life in breast cancer patients after surgery. Breast Cancer 1:123–129
Shimozuma K, Sonoo H, Ichihara K, Miyake K, Kurebayashi J, Ota K, Kiyono T (1995) The impacts of breast conserving treatment and mastectomy on the quality of life in early-stage breast cancer patients. Breast Cancer 2:35–43
Shimozuma K, Sonoo H, Ichihara K (1995) Analysis of the factors influencing the quality of life of patients with advanced or recurrent breast cancer. Surg Today 25:874–882
Shimozuma K, Tominaga T, Hayashi K, Kondo J, Kosaki G (1991) Notification of cancer in breast cancer patients (in Japanese with English abstract). Jpn J Cancer Chemother 18:2147–2153
Shimozuma K, Tominaga T, Hayashi K, Kosaki G (1991) Evaluation of quality of life in breast cancer patients (in Japanese with English abstract). J Jpn Soc Cancer Ther 26:1504–1510
Ganz PA, Lee JJ, Siau J (1991) Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 67:3131–3135
Greer S, Morris T, Pettingale KW (1979) Psychological response to breast cancer: effect on outcome. Lancet 2:785–787
Greer S, Morris T, Pettingale KW, Haybittle J (1990) Psychological response to breast cancer and 15-year outcome. Lancet 335: 49–50
Pettingale KW, Morris T, Greer S (1985) Mental attitudes to cancer: an additional prognostic factor. Lancet i:750
Spiegel D, Bloom JR, Kraemer HC, Gottheil E (1989) Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet ii:888–891
Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byrne M, Forbes JF (1992) for the Australian New Zealand Breast Cancer Trials Group. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. J Clin Oncol 10:1833–1838
Ringdal GI, Ringdal K, Kvinnsland S, Gotestam KG (1994) Quality of life of cancer patients with different prognoses. Quality Life Res 3:143–154
Ruckdeschel JC, Piantadosi S, and the Lung Cancer Study Group (1991) Quality of life assessment in lung surgery for bronchogenic carcinoma. J Theor Surg 6:201–205
Kaasa S, Mastekaasa A, Lund E (1989) Prognostic factos for patients with inoperable non-small cell lung cancer, limited disease. The important of patients’ subjective experience of disease and psychosocial well-being. Radiother Oncol 15:235–242
Shimozuma K, Sonoo H, Ichihara K (1995) Analysis of factors that improve quality of life of patients with advanced or recurrent breast cancer (in Japanese with English abstract). Jpn J Cancer Chemother 22:1095–1102
Shimozuma K, Sonoo H, Tanaka K, Ichihara K (1997) Analysis of factors that improve quality-of-life of patients with advanced or recurrent breast cancer (in Japanese with English abstract). Jpn J Breast Cancer 12:58–67
Eguchi K, Kurihara M, Shimozuma K, Hotta T, Murakami M, Suzuki N, Ishikawa K, Ogawa H, Tominaga T, Kobayashi K, Shimizu H, Tsuboi K (1993) The QOL questionnaire for cancer patients treated with anticancer drugs (in Japanese). J Jpn Soc Cancer Ther 28:1140–1144
Kurihara M, Shimizu H, Tsuboi K, Kobayashi K, Murakami M, Eguchi K, Shimozuma K (1999) Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy. Psycho-oncology 8:355–363
Lorish CD, Maisiak R (1986) The face scale: a brief, nonverbal method for assessing patient mood. Arthritis Rheum 29:906–909
Zubrod CG, Schneiderman M, Frei E III, Brindley C, Gold GL, Shnider B, Oviedo R, Gorman J, Jones R, Jonsson U, Colsky J, Chalmers T, Ferguson B, Dederick M, Holland J, Selawry O, Regelson W, Lasagna L, Owens AH Jr (1960) Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 11:7–33
Union Internationale Contre le Cancer, Breast (ICD-O 174) (1987) In: Harmer MH (ed) TNM classification of malignant tumours, 4th edn. Springer, Berlin, pp 93–99
Drettner B, Ahlbom A (1983) Quality of life and state of health for patients with cancer in the head and neck. Acta Otolaryngol 96:307–314
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de-Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F for the European Organization for Research and Treatment of Cancer Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natal Cancer Inst 85:365–376
Schipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: development and validation. J Clin Oncol 2:472–483
Priestman T, Baum M, Jones V, Fobes J (1977) Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. Br Med J 1:1248–1250
Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR (1981) Measuring the quality of life of cancer patients: a concise QL index for use by physicians. J Chron Dis 34:585–597
Coates AS, Dillenbeck CF, McNeil DR, Kaye SB, Sims K, Fox RM, Woods RL, Milton GW, Solomon J, Tattersall MH (1983) On the receiving end — II. Linear analog self assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol 19:1633–1637
Shavit Y, Lewis JW, Terman W, Gale RP, Leibeskind JC (1984) Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223:188–190
Author information
Authors and Affiliations
Additional information
This study was supported in part by a grant from the Japanese Ministry of Education, a Research Project Grant (VI, 8-604), from Kawasaki Medical School, and also by a grant from The Health Care Science Institute in Japan to K.S.
Rights and permissions
About this article
Cite this article
Shimozuma, K., Sonoo, H., Ichihara, K. et al. The Prognostic Value of Quality-of-Life Scores: Preliminary Results of an Analysis of Patients with Breast Cancer. Surg Today 30, 255–261 (2000). https://doi.org/10.1007/s005950050055
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s005950050055